These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1354616)

  • 41. The influence of beta-adrenoceptor antagonists with and without partial agonist activity on exercise tolerance and muscle lactate production.
    Lees KR; Curzio J; Farish E; Borland WW; Rubin PC
    Eur J Clin Pharmacol; 1987; 33(4):415-7. PubMed ID: 2894994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Are calcium inhibitors useful in the treatment of effort angina pectoris].
    Bounhoure JP; Fauvel JM; Puel J; Sabot G; Miquel JP
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():97-102. PubMed ID: 6407453
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The efficacy of slow-release diltiazem in the treatment of stable angina of effort: a comparison between diltiazem and placebo].
    Vizza CD; Sciomer S; Guagnozzi G; Cifarelli MT; Pastore LR; Dagianti A; Fedele F; Dagianti A
    Cardiologia; 1993 May; 38(5):311-5. PubMed ID: 8402740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Efficacy of diltiazem in elderly patients with stable effort angina].
    Acanfora D; De Caprio L; Obrizzo R; Longo F; Lirato C; Vigorito C; Giordano A; Odierna L; Cicatiello AM; Rengo F
    G Ital Cardiol; 1989 Nov; 19(11):1007-14. PubMed ID: 2695381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The antianginal effects of a new delayed-release formulation of diltiazem in patients with stable angina pectoris: its evaluation by the ergometry test and dynamic electrocardiogram].
    Metra M; Catalano A; Danesi R; Furloni R; Cuminetti S; Bellandi M; Dei Cas L
    Cardiologia; 1992 Jun; 37(6):403-11. PubMed ID: 1394348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of epanolol on quality of life.
    Jern S
    Drugs; 1989; 38 Suppl 2():71-4. PubMed ID: 2575987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease].
    Hopf R; Fleischer K; Forster A; Mohler C; Schulz PC; Kaltenbach M
    Z Kardiol; 1989; 78 Suppl 5():69-76. PubMed ID: 2698566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination treatment with trimetazidine and diltiazem in stable angina pectoris.
    Manchanda SC; Krishnaswami S
    Heart; 1997 Oct; 78(4):353-7. PubMed ID: 9404250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Myocardial ischemia with stable angina pectoris: clinico-ergometric evaluation after the use of diltiazem].
    Maranhão MF; de Castro I; Albanesi Filho FM; Bozza A; de Brito AX; Sbissa AS
    Arq Bras Cardiol; 1992 Feb; 58(2):149-55. PubMed ID: 1307461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antihypertensive and hormonal responses to beta-blockade with intrinsic sympathomimetic activity: pindolol versus epanolol.
    Simon G; Wittig VJ
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):543-7. PubMed ID: 2447403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drugs recently released in Belgium. Epanolol--Clodronate dinatrium.
    Harvengt C
    Acta Clin Belg; 1992; 47(4):285-9. PubMed ID: 1357846
    [No Abstract]   [Full Text] [Related]  

  • 52. The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease.
    Wright RA; Perrie AM; Stenhouse F; Alberti KG; Riemersma RA; MacGregor IR; Boon NA
    Eur J Clin Pharmacol; 1994; 46(3):279-82. PubMed ID: 7915237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigation of possible pharmacokinetic and pharmacodynamic interactions between epanolol and digoxin.
    Lefebvre RA; Bogaert MG; Duprez D
    Eur J Clin Pharmacol; 1990; 38(5):505-7. PubMed ID: 1974206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of timolol on cardiopulmonary exercise performance in men after myocardial infarction.
    Barvik S; Dickstein K; Aarsland T; Vik-Mo H
    Am J Cardiol; 1992 Jan; 69(3):163-8. PubMed ID: 1731452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epanolol as a model for assessing patient preference in anti-anginal drug therapy.
    Blake P; Lewis JA
    J Clin Pharmacol; 1992 Jan; 32(1):85-90. PubMed ID: 1346791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative effects of epanolol and diltiazem on exercise performance and respiratory gas exchange in angina pectoris.
    Riley M; Elborn JS; Khan MM; Stanford CF; Nicholls DP
    Eur Heart J; 1992 Aug; 13(8):1116-22. PubMed ID: 1354616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of a single oral administration of Epanolol on exercise tolerance in patients with stable effort angina pectoris.
    Vandenbosch H; Piessens J; De Geest H
    Acta Cardiol; 1991; 46(1):11-25. PubMed ID: 1674394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of beta-adrenoceptor blockade on atrial natriuretic peptide levels during exercise in angina pectoris.
    Riley M; Elborn JS; Onuoha G; Erwin C; Shaw C; Khan MM; Stanford CF; Nicholls DP
    Br J Clin Pharmacol; 1993 Feb; 35(2):209-12. PubMed ID: 8095150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
    Boberg J; Larsen FF; Pehrsson SK
    Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.